"The
Report Toxicology Cluster Chemotherapy Related Toxicity Drug
Development Pipeline Review, 2017 provides information on pricing,
market analysis, shares, forecast, and company profiles for key
industry participants. - MarketResearchReports.biz"
This report provides an overview
of the toxicology pipeline landscape. The report provides
comprehensive information on the therapeutics under development and
key players involved in therapeutic development for Chemotherapy
Induced Nausea and Vomiting, Chemotherapy Induced Neutropenia,
Chemotherapy Induced Anemia, Chemotherapy Induced Peripheral
Neuropathy and features dormant and discontinued projects.
These key indications are all
common side effects of cancer chemotherapy treatment, and result in a
substantial reduction in the patient’s quality of life.
Chemotherapy induced nausea and vomiting or CINV is nausea and
vomiting that results specifically from treatment with chemotherapy
drugs. Chemotherapy-induced neutropenia is another very common side
effect of cancer treatment. Symptoms include severe fatigue,
weakness, anxiety, lack of energy, shortness of breath, headaches,
pale appearance, rapid heart rate or palpitations, chest pain
dizziness and abdominal pain. Chemotherapy-induced anemia symptoms
include severe fatigue, weakness, anxiety, lack of energy, shortness
of breath, headaches, pale appearance, rapid heart rate or
palpitations, chest pain dizziness, cognitive impairment, loss of
sexual desire, inability to perform daily functions and/or depression
associated with anemia. Finally, chemotherapy-induced peripheral
neuropathy (CIPN) is a further potential side effect of cancer
treatment. Symptoms include pain, burning, tingling, constipation,
muscle weakness, blood pressure changes and balance problems.
The size of these pipelines ranges
from 16 in chemotherapy-induced anemia to 41 in chemotherapy-induced
neutropenia and CIPN. In CINV and CIPN, there is a relatively diverse
range of targets which are being studied, although most of these
targets are neurotransmitter receptors. On the other hand, the
pipelines for chemotherapy-induced neutropenia and anemia are far
more limited in the range of molecular targets being studied.
Scope
Which
companies are the most active within the pipeline for toxicology
therapeutics?
Which
pharmaceutical approaches are the most prominent at each stage of the
pipeline and within each indication?
To
what extent do universities and institutions play a role within this
pipeline, compared to pharmaceutical companies?
What
are the most important R&D milestones and data publications to
have happened in the field of toxicology therapeutics?
View
Report @ http://www.marketresearchreports.biz/analysis/1070458
Reasons
to buy
Understand
the overall pipeline, with an at-a-glance overview of all products in
therapeutic development for each indication
Assess
the products in development in granular detail, with an up-to-date
overview of each individual pipeline program in each indication, and
a comprehensive picture of recent updates and milestones for each
Analyze
the companies, institutions and universities currently operating in
the pipeline, and the products being fielded by each of these
Understand
the composition of the pipeline in terms of molecule type, molecular
target, mechanism of action and route of administration
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment